• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定β2-肾上腺素能受体上与沙美特罗高亲和力结合的关键氨基酸。

Identification of a key amino acid of the beta2-adrenergic receptor for high affinity binding of salmeterol.

作者信息

Isogaya M, Yamagiwa Y, Fujita S, Sugimoto Y, Nagao T, Kurose H

机构信息

Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo 113-0033, Japan.

出版信息

Mol Pharmacol. 1998 Oct;54(4):616-22.

PMID:9765503
Abstract

Transmembrane domains (TMDs) I, II, and VII of the beta2-adrenergic receptor (beta2AR) were replaced, individually or in combination, with the corresponding regions of the beta1AR, and vice versa. The beta2-selective binding of salmeterol was not affected by the exchange of TMD I between the beta1- and beta2ARs. The affinity of salmeterol was slightly decreased (32-fold) by replacement of TMD II of the beta2AR with the homologous region of the beta1AR; the affinity was strongly decreased (1870-fold) for the beta2AR with TMD VII of the beta1AR. The affinity of salmeterol was partially restored by the introduction of TMD VII, but not TMD II, of the beta2AR into the beta1AR. By analyzing alanine-substituted mutants, we found that Tyr308 in TMD VII was mainly responsible for the high affinity binding of salmeterol. Two salmeterol derivatives with the ether oxygen at different positions in the side chain showed 33- and 64-fold decreased affinities for the wild-type beta2AR, and a derivative with no ether oxygen showed 147-fold decreased affinity for the wild-type beta2AR. These results indicate that Tyr308 in TMD VII is the major amino acid conferring the beta2-selective binding of salmeterol to the beta2AR and that the position of the ether oxygen in the side chain is also important for beta2-selective binding. A three-dimensional model of the salmeterol-beta2AR complex shows that the phenyl group of Tyr308 interacts with methylene groups near the protonated amine of salmeterol and the ether oxygen interacts with Tyr316.

摘要

将β2肾上腺素能受体(β2AR)的跨膜结构域(TMD)I、II和VII分别或组合替换为β1AR的相应区域,反之亦然。β1AR和β2AR之间TMD I的交换不影响沙美特罗对β2的选择性结合。用β1AR的同源区域替换β2AR的TMD II后,沙美特罗的亲和力略有下降(32倍);用β1AR的TMD VII替换β2AR后,其亲和力大幅下降(1870倍)。将β2AR的TMD VII而非TMD II引入β1AR后,沙美特罗的亲和力部分恢复。通过分析丙氨酸取代突变体,我们发现TMD VII中的Tyr308是沙美特罗高亲和力结合的主要原因。两种侧链醚氧位置不同的沙美特罗衍生物对野生型β2AR的亲和力分别下降了33倍和64倍,一种无醚氧的衍生物对野生型β2AR的亲和力下降了147倍。这些结果表明,TMD VII中的Tyr308是赋予沙美特罗对β2ARβ2选择性结合的主要氨基酸,并且侧链中醚氧的位置对β2选择性结合也很重要。沙美特罗-β2AR复合物的三维模型显示,Tyr308的苯基与沙美特罗质子化胺附近的亚甲基相互作用,醚氧与Tyr316相互作用。

相似文献

1
Identification of a key amino acid of the beta2-adrenergic receptor for high affinity binding of salmeterol.确定β2-肾上腺素能受体上与沙美特罗高亲和力结合的关键氨基酸。
Mol Pharmacol. 1998 Oct;54(4):616-22.
2
Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor.通过“锚定”激动剂结合实现G蛋白偶联受体的持续激活。沙美特罗别构位点在β2-肾上腺素能受体内的分子定位。
J Biol Chem. 1996 Sep 27;271(39):24029-35. doi: 10.1074/jbc.271.39.24029.
3
Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.野生型和组成型活性β2-肾上腺素能受体的两个丝氨酸残基对与β2-选择性激动剂相互作用的差异贡献。
Br J Pharmacol. 1997 Jul;121(6):1059-64. doi: 10.1038/sj.bjp.0701229.
4
Domains of beta1 and beta2 adrenergic receptors to bind subtype selective agonists.β1和β2肾上腺素能受体与亚型选择性激动剂结合的结构域。
Life Sci. 1998;62(17-18):1513-7. doi: 10.1016/s0024-3205(98)00099-x.
5
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.G蛋白偶联受体工程为β2肾上腺素能受体功能带来了高分辨率的结构见解。
Science. 2007 Nov 23;318(5854):1266-73. doi: 10.1126/science.1150609. Epub 2007 Oct 25.
6
Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling.肺泡上皮细胞主动钠转运的上调依赖于β2-肾上腺素能受体信号传导。
Circ Res. 2004 Apr 30;94(8):1091-100. doi: 10.1161/01.RES.0000125623.56442.20. Epub 2004 Mar 11.
7
Probing the salmeterol binding site on the beta 2-adrenergic receptor using a novel photoaffinity ligand, [(125)I]iodoazidosalmeterol.使用新型光亲和配体[(125)I]碘叠氮沙美特罗探究β2-肾上腺素能受体上的沙美特罗结合位点。
Biochemistry. 1999 Aug 31;38(35):11278-86. doi: 10.1021/bi9910676.
8
An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine.一种针对高原肺水肿的计算机模拟方法——人β2肾上腺素能受体的分子建模及其与沙美特罗和硝苯地平的相互作用。
J Mol Model. 2008 Sep;14(9):849-56. doi: 10.1007/s00894-008-0322-z. Epub 2008 May 30.
9
Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.利用磷酸丝氨酸特异性抗体对β2-肾上腺素能受体的cAMP依赖性蛋白激酶激动剂刺激和G蛋白偶联受体激酶磷酸化进行表征。
Mol Pharmacol. 2004 Jan;65(1):196-206. doi: 10.1124/mol.65.1.196.
10
Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.β1-和β2-肾上腺素能受体亚型的异源二聚化优化了心脏收缩力的β-肾上腺素能调节。
Circ Res. 2005 Aug 5;97(3):244-51. doi: 10.1161/01.RES.0000176764.38934.86. Epub 2005 Jul 7.

引用本文的文献

1
-(4-Bromo-2,5-Dimethoxyphenethyl)-6-(4-Phenylbutoxy)Hexan-1-Amine (XOB): A Novel Phenylalkylamine Antagonist of Serotonin 2A Receptors and Voltage-Gated Sodium Channels.-(4-溴-2,5-二甲氧基苯乙基)-6-(4-苯基丁氧基)己-1-胺(XOB):一种新型的苯乙胺类血清素 2A 受体和电压门控钠离子通道拮抗剂。
Mol Pharmacol. 2024 Jul 17;106(2):92-106. doi: 10.1124/molpharm.123.000837.
2
Clustering of atoms relative to vector space in the Z-matrix coordinate system and 'graphical fingerprint' analysis of 3D pharmacophore structure.Z矩阵坐标系中原子相对于向量空间的聚类以及三维药效团结构的“图形指纹”分析。
Mol Divers. 2024 Dec;28(6):4087-4104. doi: 10.1007/s11030-023-10798-1. Epub 2024 Jan 28.
3
Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines.
延长吸入药物肺部暴露的药物策略。
Acta Pharm Sin B. 2021 Aug;11(8):2565-2584. doi: 10.1016/j.apsb.2021.05.015. Epub 2021 May 21.
4
Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting 2-Adrenergic Receptor Agonists.长效 2-肾上腺素能受体激动剂的膜介导受体进入和结合机制。
Mol Pharmacol. 2021 Oct;100(4):406-427. doi: 10.1124/molpharm.121.000285. Epub 2021 Aug 1.
5
G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.哮喘治疗中的 G 蛋白偶联受体:药理学和药物作用。
Pharmacol Rev. 2020 Jan;72(1):1-49. doi: 10.1124/pr.118.016899.
6
Structural insights into binding specificity, efficacy and bias of a βAR partial agonist.βAR 部分激动剂结合特异性、效力和偏向性的结构见解。
Nat Chem Biol. 2018 Nov;14(11):1059-1066. doi: 10.1038/s41589-018-0145-x. Epub 2018 Oct 16.
7
What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?胺能受体的晶体结构能为我们设计亚型选择性配体提供哪些信息?
Pharmacol Rev. 2015;67(1):198-213. doi: 10.1124/pr.114.009944.
8
Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.通过对接和分子动力学模拟研究芬特罗对映异构体和衍生物与 β₂-肾上腺素能受体结合位点的分子相互作用。
J Mol Model. 2013 Nov;19(11):4919-30. doi: 10.1007/s00894-013-1981-y. Epub 2013 Sep 17.
9
Predicting novel binding modes of agonists to β adrenergic receptors using all-atom molecular dynamics simulations.运用全原子分子动力学模拟预测激动剂与β肾上腺素能受体的新型结合模式。
PLoS Comput Biol. 2011 Jan 6;7(1):e1001053. doi: 10.1371/journal.pcbi.1001053.
10
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.激动剂和部分激动剂在β(1)-肾上腺素能受体上作用的结构基础。
Nature. 2011 Jan 13;469(7329):241-4. doi: 10.1038/nature09746.